Toll Free: 1-888-928-9744
Published: Dec, 2014 | Pages:
45 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
NeoStem, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'NeoStem, Inc. - Product Pipeline Review - 2014', provides an overview of the NeoStem, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of NeoStem, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of NeoStem, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of NeoStem, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the NeoStem, Inc.'s pipeline products Reasons to buy - Evaluate NeoStem, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of NeoStem, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the NeoStem, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of NeoStem, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of NeoStem, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of NeoStem, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 NeoStem, Inc. Snapshot 5 NeoStem, Inc. Overview 5 Key Information 5 Key Facts 5 NeoStem, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 NeoStem, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 NeoStem, Inc. - Pipeline Products Glance 13 NeoStem, Inc. - Late Stage Pipeline Products 13 Phase III Products/Combination Treatment Modalities 13 NeoStem, Inc. - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Phase I Products/Combination Treatment Modalities 15 NeoStem, Inc. - Early Stage Pipeline Products 16 Preclinical Products/Combination Treatment Modalities 16 Discovery Products/Combination Treatment Modalities 17 NeoStem, Inc. - Drug Profiles 18 Cancer Stem Cell Therapy 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Melapuldencel-T 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 AMR-001 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Dendritic Cell Therapy for Renal Cell Carcinoma 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Cell Therapy for CNS, Respiratory, Immunology and Metabolic Disorders 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Mesenchymal Cells for Wound Care 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Stem Cell Therapy for Macular Degeneration and Glaucoma 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Stem Cell Therapy for Osteoporosis and Periodontitis 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Stem Cell Therapy for Radiation Exposure 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Stem Cell Therapy for Sciatic Nerve Regeneration 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Stem Cell Therapy for AMD and Retinitis Pigmentosa 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 NeoStem, Inc. - Pipeline Analysis 31 NeoStem, Inc. - Pipeline Products by Route of Administration 31 NeoStem, Inc. - Pipeline Products by Molecule Type 32 NeoStem, Inc. - Recent Pipeline Updates 33 NeoStem, Inc. - Dormant Projects 42 NeoStem, Inc. - Locations And Subsidiaries 43 Head Office 43 Other Locations & Subsidiaries 43 Appendix 44 Methodology 44 Coverage 44 Secondary Research 44 Primary Research 44 Expert Panel Validation 44 Contact Us 45 Disclaimer 45
List of Tables NeoStem, Inc., Key Information 5 NeoStem, Inc., Key Facts 5 NeoStem, Inc. - Pipeline by Indication, 2014 8 NeoStem, Inc. - Pipeline by Stage of Development, 2014 9 NeoStem, Inc. - Monotherapy Products in Pipeline, 2014 10 NeoStem, Inc. - Partnered Products in Pipeline, 2014 11 NeoStem, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12 NeoStem, Inc. - Phase III, 2014 13 NeoStem, Inc. - Phase II, 2014 14 NeoStem, Inc. - Phase I, 2014 15 NeoStem, Inc. - Preclinical, 2014 16 NeoStem, Inc. - Discovery, 2014 17 NeoStem, Inc. - Pipeline by Route of Administration, 2014 31 NeoStem, Inc. - Pipeline by Molecule Type, 2014 32 NeoStem, Inc. - Recent Pipeline Updates, 2014 33 NeoStem, Inc. - Dormant Developmental Projects,2014 42 NeoStem, Inc., Subsidiaries 43
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.